According to Fortune Business Insights, the global atherectomy devices market size was valued at USD 862.62 million in 2025 and is projected to grow from USD 922.09 million in 2026 to USD 1,571.7 million by 2034, exhibiting a CAGR of 6.89% during the forecast period. The increasing prevalence of cardiovascular diseases and rising demand for minimally invasive vascular procedures are driving the growth of the global market.

Rising Cardiovascular Disease Cases Fuel Market Growth

The growing incidence of peripheral artery disease (PAD) and coronary artery disease (CAD) is one of the major factors accelerating the demand for atherectomy devices worldwide. Sedentary lifestyles, obesity, diabetes, smoking habits, and aging populations are significantly contributing to vascular disorders, increasing the need for advanced treatment solutions.

Atherectomy devices are widely used to remove plaque deposits from blood vessels, helping restore blood flow and reduce complications associated with arterial blockages. Compared to traditional surgical procedures, atherectomy treatments offer shorter recovery periods, lower risks, and improved patient outcomes, making them increasingly preferred by healthcare providers.

Technological Advancements Supporting Market Expansion

Continuous advancements in medical technology are transforming the atherectomy devices market. Manufacturers are introducing highly advanced devices featuring improved precision, enhanced plaque removal efficiency, and image-guided navigation systems. Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are helping physicians perform accurate and minimally invasive procedures.

Additionally, the development of low-profile catheters and advanced rotational and orbital atherectomy systems is improving treatment effectiveness for heavily calcified arterial lesions. These innovations are expected to create significant growth opportunities for market players during the forecast period.

Download Free Sample: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/atherectomy-devices-market-111844

Peripheral Artery Disease Segment Holds Major Share

Based on application, the peripheral artery disease segment dominates the atherectomy devices market due to the increasing number of PAD patients globally. Atherectomy procedures are commonly used to treat blocked peripheral arteries, especially in elderly patients suffering from diabetes and hypertension.

Meanwhile, the coronary artery disease segment is expected to witness substantial growth owing to the rising number of minimally invasive cardiovascular interventions across hospitals and specialty clinics worldwide.

North America Leads Global Atherectomy Devices Market

North America holds the largest share of the global atherectomy devices market due to advanced healthcare infrastructure, increasing healthcare expenditure, and high adoption of innovative cardiovascular technologies. The presence of leading medical device manufacturers and favorable reimbursement policies further support regional market growth.

Europe also represents a significant market owing to rising awareness regarding cardiovascular disorders and increasing adoption of minimally invasive surgical procedures. The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period due to improving healthcare facilities, growing medical tourism, and expanding patient populations in countries such as China and India.

Key Companies Focus on Innovation and Expansion

Leading players operating in the atherectomy devices market are focusing on product innovations, partnerships, mergers, and acquisitions to strengthen their market position. Companies are heavily investing in research and development activities to launch safer and more efficient atherectomy technologies.

Some major companies operating in the market include:

• Boston Scientific Corporation
• Abbott
• Medtronic
• Koninklijke Philips N.V.
• Terumo Corporation
• AngioDynamics
• Avinger
• BD

These companies are continuously working toward enhancing treatment outcomes and expanding their global presence.

Future Outlook of the Atherectomy Devices Market

The future of the atherectomy devices market appears highly promising due to the increasing adoption of minimally invasive vascular treatments and ongoing advancements in interventional cardiology. Growing awareness regarding early diagnosis and treatment of cardiovascular diseases is expected to further boost market demand over the coming years.

Furthermore, rising healthcare investments in emerging economies and increasing demand for advanced vascular treatment solutions are likely to create lucrative opportunities for market players through 2034.

Source: https://www.fortunebusinessinsights.com/atherectomy-devices-market-111844

Trending FAQs

What is driving the growth of the Atherectomy Devices Market?

The increasing prevalence of cardiovascular diseases and rising preference for minimally invasive procedures are major growth drivers.

Which region dominates the Atherectomy Devices Market?

North America dominates the market due to advanced healthcare infrastructure and strong adoption of cardiovascular technologies.

Which application segment leads the Atherectomy Devices Market?

The peripheral artery disease (PAD) segment holds the largest market share globally.

Who are the key players in the Atherectomy Devices Market?

Major companies include Boston Scientific Corporation, Abbott, Medtronic, and Terumo Corporation.

What are the latest trends in the Atherectomy Devices Market?

Image-guided atherectomy systems, advanced catheters, and minimally invasive vascular procedures are major industry trends.